ヘリコバクター・ピロリの非侵襲的検査市場：検査タイプ、検査方法、エンドユーザー別-2025-2030年の世界予測

ヘリコバクター・ピロリの非侵襲的検査市場は、2023年に10億6,000万米ドルと評価され、2024年には11億2,000万米ドルに達すると予測され、CAGR 5.70％で成長し、2030年には15億7,000万米ドルに達すると予測されています。

ヘリコバクター・ピロリ（H.ピロリ）非侵襲的検査は、胃腸診断の重要な要素であり、内視鏡処置を必要とせずにピロリ菌感染を検出できます。この検査法には、尿素呼気試験、便中抗原検査、血液抗体検査があり、それぞれ精度、コスト、患者の利便性の点で特有の利点があります。非侵襲的検査の必要性は、ピロリ菌が消化性潰瘍や胃がんを含む様々な胃腸疾患と関連しており、早期発見が効果的な治療と管理に不可欠であることから生じています。これらの検査の主なエンドユーザーには、病院、診断研究所、クリニックが含まれ、在宅診断ソリューションの需要増加により、在宅ヘルスケア環境での用途が拡大しています。

市場の成長要因としては、消化器疾患の有病率の上昇、ピロリ菌の健康への影響に関する意識の高まり、非侵襲的診断法へのシフトなどが挙げられます。検査の感度や特異度の向上など、技術の進歩が市場機会を拡大しています。医療支出の増加とインフラの改善が市場拡大のための肥沃な土壌を提供する新興市場に大きな機会があります。このような機会を捉えるための推奨事項としては、費用対効果が高く携帯可能な検査技術革新に注力すること、十分なサービスを受けていない地域での流通を拡大することなどが挙げられます。

しかし、低資源地域では高度な診断施設へのアクセスが限られていることや、規制基準が厳しいことなどが市場成長の課題となっています。さらに、侵襲的な代替検査法の存在も競合の原因となります。こうした課題を克服するため、企業は検査の精度と使いやすさを向上させる技術に投資し、ヘルスケア専門家と患者を問わず、非侵襲的な選択肢に対する認識と理解を高めるよう提唱することが推奨されます。イノベーションは、デジタルヘルスプラットフォームと統合し、シームレスな健康モニタリングとデータ利用を可能にする検査の開発に焦点を当てるべきです。全体として、市場はダイナミックであり、企業が技術の進歩を効果的に活用し、アクセシビリティの問題に対処する戦略を立てれば、大きな成長が期待できます。

市場力学：急速に進化するヘリコバクター・ピロリの非侵襲的検査市場の主要市場インサイトを公開

ヘリコバクター・ピロリの非侵襲的検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ヘリコバクター・ピロリ菌感染の有病率の増加
  • 胃潰瘍の有病率の上昇
  • 適切な診断のための政府による感染に関する意識の高まり
• 市場抑制要因
  • 有病率の高い地域でも低い診断率
• 市場機会
  • リアルタイムPCRや化学発光免疫測定法（CLIA）など、新しく先進的な非侵襲的検査の利用可能性
  • ポイント・オブ・ケア検査機器に対する需要の高まり
• 市場の課題
  • 感染症の無症候性、厳しい規制基準

ポーターの5つの力：ヘリコバクター・ピロリの非侵襲的検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヘリコバクター・ピロリの非侵襲的検査市場における外部からの影響の把握

外部マクロ環境要因は、ヘリコバクター・ピロリの非侵襲的検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヘリコバクター・ピロリの非侵襲的検査市場における競合情勢の把握

ヘリコバクター・ピロリの非侵襲的検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヘリコバクター・ピロリの非侵襲的検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヘリコバクター・ピロリの非侵襲的検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヘリコバクター・ピロリの非侵襲的検査市場における成功への道筋を描く

ヘリコバクター・ピロリの非侵襲的検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヘリコバクター・ピロリ菌感染症の蔓延
    • 胃潰瘍の罹患率の上昇
    • 適切な診断のために政府による感染に関する意識向上
  • 抑制要因
    • 有病率の高い地域でも診断率は低い
  • 機会
    • リアルタイムPCRや化学発光免疫測定法（CLIA）などの新しい高度な非侵襲的検査の利用可能性
    • ポイントオブケア検査機器の需要増加
  • 課題
    • 感染の無症状性と厳格な規制基準
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヘリコバクター・ピロリの非侵襲的検査市場テストタイプ別

• 呼気検査
• 血清検査
• 便抗原検査

第7章 ヘリコバクター・ピロリの非侵襲的検査市場試験方法別

• 実験室ベースのテスト
• ポイントオブケア検査
• 迅速検査キット

第8章 ヘリコバクター・ピロリの非侵襲的検査市場：エンドユーザー別

• クリニック
• 病院

第9章 南北アメリカのヘリコバクター・ピロリの非侵襲的検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のヘリコバクター・ピロリの非侵襲的検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのヘリコバクター・ピロリの非侵襲的検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Alere Inc.
• Bio-Rad Laboratories, Inc.
• Biomerica, Inc.
• Certest Biotec SL
• CorisBioconcept SPRL
• DiaSorin S.P.A.
• Exalenz Bioscience Ltd
• Medline Industries, Inc.
• Meridian Bioscience Inc.
• Quidel Corporation
• Sekisui Diagnostics, LLC
• Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
• Siemens Healthcare Private Limited
• Thermo Fisher Scientific, Inc

LIST OF FIGURES

• FIGURE 1. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET RESEARCH PROCESS
• FIGURE 2. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY BREATH TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LABORATORY-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POINT-OF-CARE TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 30. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 47. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 50. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 102. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 114. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 117. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Helicobacter Pylori Non-invasive Testing Market was valued at USD 1.06 billion in 2023, expected to reach USD 1.12 billion in 2024, and is projected to grow at a CAGR of 5.70%, to USD 1.57 billion by 2030.

Helicobacter pylori (H. pylori) non-invasive testing is a crucial component of gastrointestinal diagnostics, allowing for the detection of H. pylori infections without the need for endoscopic procedures. This testing method encompasses urea breath tests, stool antigen tests, and blood antibody tests, with each offering specific advantages in terms of accuracy, cost, and patient convenience. The necessity of non-invasive testing arises from H. pylori's association with various gastrointestinal disorders, including peptic ulcers and gastric cancer, making early detection critical for effective treatment and management. The primary end-users of these tests include hospitals, diagnostic laboratories, and clinics, with a growing application in home healthcare settings, driven by increasing demand for at-home diagnostic solutions.

Growth factors in the market include rising prevalence of gastrointestinal diseases, increasing awareness about H. pylori's health implications, and the shift towards non-invasive diagnostic methods. Advances in technology, such as improved sensitivity and specificity of tests, expand market opportunities. A significant opportunity lies in emerging markets where increasing healthcare expenditure and improving infrastructure provide fertile ground for market expansion. Recommendations for capturing these opportunities include focusing on cost-effective and portable testing innovations and expanding distribution in underserved regions.

However, market growth is challenged by factors such as limited accessibility to advanced diagnostic facilities in low-resource areas and strict regulatory norms. Additionally, the presence of alternative, invasive testing methods can pose competition. To overcome these challenges, businesses are advised to invest in technology that enhances test accuracy and ease of use, and to advocate for increased awareness and understanding of non-invasive options among healthcare professionals and patients alike. Innovation should focus on developing tests that integrate with digital health platforms, enabling seamless health monitoring and data use. Overall, the market is dynamic, with strong growth potential, provided companies effectively harness technological advancements and strategize to address accessibility issues.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Helicobacter Pylori Non-invasive Testing Market

The Helicobacter Pylori Non-invasive Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of Helicobacter pylori bacterial infection
  • Rising prevalence of gastric ulcer
  • Increasing awareness regarding infection by the government for proper diagnosis
• Market Restraints
  • Low diagnosis rates even in high prevalence geographies
• Market Opportunities
  • Availability of new and advanced non-invasive tests such as real-time PCR and Chemiluminescence Immunoassay (CLIA)
  • Growing demand for point of care testing devices
• Market Challenges
  • Asymptomatic nature of the infection, and stringent regulatory norms

Porter's Five Forces: A Strategic Tool for Navigating the Helicobacter Pylori Non-invasive Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Helicobacter Pylori Non-invasive Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Helicobacter Pylori Non-invasive Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Helicobacter Pylori Non-invasive Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Helicobacter Pylori Non-invasive Testing Market

A detailed market share analysis in the Helicobacter Pylori Non-invasive Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Helicobacter Pylori Non-invasive Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Helicobacter Pylori Non-invasive Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Helicobacter Pylori Non-invasive Testing Market

A strategic analysis of the Helicobacter Pylori Non-invasive Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Helicobacter Pylori Non-invasive Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Inc., Biomerica, Inc., Certest Biotec SL, CorisBioconcept SPRL, DiaSorin S.P.A., Exalenz Bioscience Ltd, Medline Industries, Inc., Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, LLC, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., Siemens Healthcare Private Limited, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Helicobacter Pylori Non-invasive Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test Type, market is studied across Breath Test, Serology Test, and Stool Antigen Test.
• Based on Test Method, market is studied across Laboratory-Based Tests, Point-of-care Tests, and Rapid Test Kit.
• Based on End-User, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of Helicobacter pylori bacterial infection
    • 5.1.1.2. Rising prevalence of gastric ulcer
    • 5.1.1.3. Increasing awareness regarding infection by the government for proper diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. Low diagnosis rates even in high prevalence geographies
  • 5.1.3. Opportunities
    • 5.1.3.1. Availability of new and advanced non-invasive tests such as real-time PCR and Chemiluminescence Immunoassay (CLIA)
    • 5.1.3.2. Growing demand for point of care testing devices
  • 5.1.4. Challenges
    • 5.1.4.1. Asymptomatic nature of the infection, and stringent regulatory norms
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Helicobacter Pylori Non-invasive Testing Market, by Test Type

• 6.1. Introduction
• 6.2. Breath Test
• 6.3. Serology Test
• 6.4. Stool Antigen Test

7. Helicobacter Pylori Non-invasive Testing Market, by Test Method

• 7.1. Introduction
• 7.2. Laboratory-Based Tests
• 7.3. Point-of-care Tests
• 7.4. Rapid Test Kit

8. Helicobacter Pylori Non-invasive Testing Market, by End-User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals

9. Americas Helicobacter Pylori Non-invasive Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Helicobacter Pylori Non-invasive Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Helicobacter Pylori Non-invasive Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alere Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Biomerica, Inc.
• 5. Certest Biotec SL
• 6. CorisBioconcept SPRL
• 7. DiaSorin S.P.A.
• 8. Exalenz Bioscience Ltd
• 9. Medline Industries, Inc.
• 10. Meridian Bioscience Inc.
• 11. Quidel Corporation
• 12. Sekisui Diagnostics, LLC
• 13. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
• 14. Siemens Healthcare Private Limited
• 15. Thermo Fisher Scientific, Inc